Pictet Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
26,807
-6,632
-20% -$44.1K ﹤0.01% 1921
2026
Q1
$182K Buy
33,439
+7,093
+27% +$39.8K ﹤0.01% 1958
2025
Q4
$184K Hold
26,346
﹤0.01% 1944
2025
Q3
$204K Hold
26,346
﹤0.01% 1869
2025
Q2
$229K Buy
26,346
+5,377
+26% +$39K ﹤0.01% 1768
2025
Q1
$167K Hold
20,969
﹤0.01% 1835
2024
Q4
$191K Hold
20,969
﹤0.01% 1867
2024
Q3
$192K Hold
20,969
﹤0.01% 1828
2024
Q2
$205K Hold
20,969
﹤0.01% 1751
2024
Q1
$317K Hold
20,969
﹤0.01% 1516
2023
Q4
$452K Hold
20,969
﹤0.01% 1327
2023
Q3
$390K Buy
+20,969
New +$489K ﹤0.01% 1342

Other funds holding TDOC

Pictet Asset Management's TDOC Position: Q2 2026 in Review

Pictet Asset Management reduced its Teladoc Health (TDOC) stake by 20% in Q2 2026, selling an estimated $44.1K and leaving 26,807 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Pictet Asset Management first reported a position in TDOC in Q3 2023 and has held it in 12 quarters since. The position peaked at $452K in Q4 2023. 164 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Pictet Asset Management held 26,807 shares of Teladoc Health worth $227K as of Q2 2026.
  • Pictet Asset Management sold 6,632 Teladoc Health shares in Q2 2026, an estimated $44.1K.
  • Teladoc Health made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1921 holding.
  • Pictet Asset Management first reported a position in Teladoc Health in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Teladoc Health position peaked at $452K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.